Literature DB >> 6451447

Non-specific broncho-reactivity obtained with an ultrasonic aerosol of distilled water.

L Allegra, S Bianco.   

Abstract

A mist of distilled water obtained by means of powerful high density ultrasonic device has been used as nonspecific challenge test for assessing bronchial hyperreactivity in asthmatics. It looks an easier and/or more physiologic stimulation when compared with the nebulisation of other substances such as histamine, acetylcholine, methacholine, carbachol, citric acid, prostaglandins. Furthermore, this test shows good correspondence to the history of fog-induced asthma. In ten normal subjects the ultrasonic mist of H2O doesn't produce any functional change, while in thirteen asthmatic patients it results in a clear-cut bronchoconstriction, with a maximal evidence within 10 minutes and a subsequent decrease up to 30 minutes. Premedication with propranolol doesn't change the negativity of the test in normal subjects. Ultrasonic mist of saline doesn't determine any remarkable bronchoconstriction in asthmatics. In forty asthmatics a trial has been then carried out on prevention of water-induced bronchoconstriction by different pharmacologic means. Ipratropium fails to protect significantly the patients, while Disodium-cromoglycate, Salbutamol and prostaglandins E reduce significantly the entity of the so induced bronchospasm. These observations support the hypothesis of a mast cell mediated mechanism and disprove the vagal contribution to this type of bronchial challenge.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6451447

Source DB:  PubMed          Journal:  Eur J Respir Dis Suppl        ISSN: 0106-4347


  12 in total

Review 1.  Prevention of bronchial hyperreactivity in children.

Authors:  H Lindemann
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  TRP channels in airway smooth muscle as therapeutic targets.

Authors:  Martin Gosling; Chris Poll; Su Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

3.  Osmolality and pH of anti-asthmatic drug solutions.

Authors:  K N Desager; H P Van Bever; W J Stevens
Journal:  Agents Actions       Date:  1990-11

4.  Adverse reactions to the non-drug constituents of nebuliser solutions.

Authors:  R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

5.  A new risk of occupational disease: allergic asthma and rhinoconjunctivitis in persons working with beneficial arthropods.

Authors:  C Cipolla; G Lugo; C Sassi; R Bonfiglioli; S Maini; M G Tommasini; G B Raffi
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

6.  Sodium cromoglycate and atropine block the fall in FEV1 but not the cough induced by hypotonic mist.

Authors:  R W Fuller; J G Collier
Journal:  Thorax       Date:  1984-10       Impact factor: 9.139

7.  Potassium tolerance and bronchial reactivity in asthmatic and nonasthmatic atopic subjects.

Authors:  L Marazzini; R Cavestri; B Mastropasqua; M Bozzoni; M Pacetti; E Longhini
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

8.  Humid air increases airway resistance in asthmatic subjects.

Authors:  M L Aitken; J J Marini; B H Culver
Journal:  West J Med       Date:  1988-09

9.  The effect of intravenously administered salbutamol on serum potassium in asthmatic and nonasthmatic atopic subjects.

Authors:  L Marazzini; A Pelucchi; M Bozzoni; B Mastropasqua; E Longhini
Journal:  J Clin Immunol       Date:  1985-05       Impact factor: 8.317

10.  Effect of nedocromil sodium on aspecific bronchial hyper-reactivity in asthmatic children.

Authors:  A Fiocchi; P Signoroni; P Bruni; M Galeone; E Decet; S Bogacki
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.